Intracellular trafficking mechanisms of renal C1C and AQP channels

肾C1C和AQP通道的细胞内转运机制

基本信息

  • 批准号:
    12144204
  • 负责人:
  • 金额:
    $ 32.77万
  • 依托单位:
  • 依托单位国家:
    日本
  • 项目类别:
    Grant-in-Aid for Scientific Research on Priority Areas
  • 财政年份:
    2000
  • 资助国家:
    日本
  • 起止时间:
    2000 至 2004
  • 项目状态:
    已结题

项目摘要

We investigated intracellular sorting mechanisms of renal CLC chloride-channels and AQP water-channels, especially focusing on the disease-causing mutants of these channels.1. Molecular pathogenesis of autosomal-dominant type nephrogenic diabetes insipidus (AD-NDI) in AQP2. We found five families of AD-NDI. Sequencing of AQP2-gene revealed the heterozygous frame-shift mutations in all patients, resulting in addition of 61 amino-acids to carboxy-terminus of AQP2. In contrast to the apical localization of wild-type AQP2 expressed in MDCK cells, the disease-causing mutants basolaterally distributed. Furthermore, the mutants recruited the wild-type AQP2 to the basolateral membrane when co-expressed, showing dominant-negative effect. We also found that a di-luecine motif in the mutant was responsible for the basolateral sorting. To confirm whether this mechanism worked in vivo, we generated by gene-targeting a knock-in mouse expressing the mutant AQP2. As expected, the mice showed AD-NDI. A … More pical localization of wild-type AQP2 was significantly impaired by the mutant AQP2-expression. Further analysis of this mouse model will help to clarify the molecular mechanisms of AD-NDI and to develop strategy for treatments of AD-NDI.2. Molecular mechanisms of Bartter syndrome caused by mutations in the BSND-gene. The BSND-gene encodes barttin, which functions as beta-subunit of Cl-channel C1C-K. We determined intracellular localization of C1C-K2 with or without co-expressing barttin in MDCK cells. Barttin clearly recruited C1C-K2 to the plasma membranes. R8L barttin, a disease-causing mutant, was retained in endoplasmic reticulum (ER). However, it could bind C1C-K2. Accordingly, C1C-K2 was also retained in ER. This might be a major mechanism of Bartter syndrome caused by barttin mutaions.3. Chloride-shunt theory as a cause of pseudohypoaldosteronism type II (PHAII). Mutaions of WNK-kinases were identified to be responsible for PHAII. However, its molecular pathogenesis was not determined. We demonstrated that a disease-causing WNK4-mutant increased paracellular chloride-permeability and claudin-phosphorylation. Less
我们研究了肾脏ClC氯通道和水通道的细胞内分选机制,特别是这些通道的致病突变。AQP2常染色体显性遗传型肾源性尿崩症(AD-NDI)的分子发病机制我们发现了五个AD-NDI家系。对AQP2基因进行测序发现,所有患者都存在杂合性移码突变,导致AQP2的羧基末端增加了61个氨基酸。与野生型AQP2在MDCK细胞中表达的顶端定位相反,致病突变体基本呈基线分布。此外,当共表达时,突变体将野生型AQP2募集到基侧膜上,表现出显性-负效应。我们还发现,突变体中的一个双侧基序负责碱侧排序。为了证实这一机制在体内是否起作用,我们通过对表达突变AQP2的敲入小鼠进行基因打靶产生了这种机制。不出所料,这些小鼠出现了AD-NDI。A…突变型AQP2的表达显著削弱了野生型AQP2更常见的定位。对这一小鼠模型的进一步分析将有助于阐明AD-NDI的分子机制,并为AD-NDI的治疗制定策略。BSND基因突变引起巴特综合征的分子机制BSND-基因编码Barttin,其功能是氯离子通道C1C-K的β-亚基。我们确定了在MDCK细胞中有或没有共表达Barttin的C1C-K2的细胞内定位。Barttin清楚地将C1C-K2招募到质膜上。致病突变体R8L barttin保留在内质网(ER)中。然而,它可以结合C1C-K2。因此,C1C-K2也保留在内质网中。这可能是Barttin突变导致巴特综合征的主要机制。氯分流理论是假性醛固酮增多症II型(PHAII)的原因。WNK-激酶突变被确定为PHAII的致病因素。然而,其分子发病机制尚未确定。我们证明了致病的WNK4突变体增加了细胞旁氯离子的通透性和Claudin的磷酸化。较少

项目成果

期刊论文数量(211)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Transcriptional regulation of the CLC-K1 promoter by myc-associated zinc finger protein and kidney-enriched Kruppel-like factor, a novel zinc finger repressor
  • DOI:
    10.1128/mcb.20.19.7319-7331.2000
  • 发表时间:
    2000-10-01
  • 期刊:
  • 影响因子:
    5.3
  • 作者:
    Uchida, S;Tanaka, Y;Marumo, F
  • 通讯作者:
    Marumo, F
Isolation and characterization of the human CLC-5 chloride channel gene promoter
  • DOI:
    10.1016/s0378-1119(00)00493-5
  • 发表时间:
    2000-12-31
  • 期刊:
  • 影响因子:
    3.5
  • 作者:
    Hayama, A;Uchida, S;Marumo, F
  • 通讯作者:
    Marumo, F
Expression of CLC-KB gene promoter in the mouse cochlea.
CLC-KB基因启动子在小鼠耳蜗中的表达。
  • DOI:
  • 发表时间:
    2003
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Minamisawa S;Oshikawa J;Takeshima H;Hoshijima M;Wang Y;Chien KR;Ishikawa Y;Matsuoka R;Maehara H et al.
  • 通讯作者:
    Maehara H et al.
Kidney-specific chloride channel, OmC1C-K, predominantly expressed in the diluting segment of freshwater-adapted tilapia kidney.
肾脏特异性氯离子通道 OmC1C-K 主要在淡水适应罗非鱼肾脏的稀释段中表达。
Aquaporin-2 is retrieved to the apical storage compartment via early endosomes and phosphatidylinositol 3-kinase-dependent pathway
  • DOI:
    10.1210/en.2004-0073
  • 发表时间:
    2004-09-01
  • 期刊:
  • 影响因子:
    4.8
  • 作者:
    Tajika, Y;Matsuzaki, T;Takata, K
  • 通讯作者:
    Takata, K
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

UCHIDA Shinichi其他文献

UCHIDA Shinichi的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('UCHIDA Shinichi', 18)}}的其他基金

Efficient chemical library screening for WNK signaling inhibitors byinhibiting WNK-SPAK interaction
通过抑制 WNK-SPAK 相互作用有效筛选 WNK 信号抑制剂的化学库
  • 批准号:
    23659439
  • 财政年份:
    2011
  • 资助金额:
    $ 32.77万
  • 项目类别:
    Grant-in-Aid for Challenging Exploratory Research
A novel WNK signal cascade regulating renal transporters
一种新型 WNK 信号级联调节肾转运蛋白
  • 批准号:
    20249047
  • 财政年份:
    2008
  • 资助金额:
    $ 32.77万
  • 项目类别:
    Grant-in-Aid for Scientific Research (A)
Analysis of abnormal chloride transport in the pathogenesis of renal electrolyte disorders
肾电解质紊乱发病机制中氯离子转运异常的分析
  • 批准号:
    18390246
  • 财政年份:
    2006
  • 资助金额:
    $ 32.77万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Identification of renal transportsomes by analyzing disease-causing mutants of transporters and their regulators.
通过分析转运蛋白及其调节因子的致病突变体来鉴定肾转运体。
  • 批准号:
    17081009
  • 财政年份:
    2005
  • 资助金额:
    $ 32.77万
  • 项目类别:
    Grant-in-Aid for Scientific Research on Priority Areas
Regulation of CLC chloride channels by their beta-subunits
CLC 氯离子通道的 β 亚基调节
  • 批准号:
    16390241
  • 财政年份:
    2004
  • 资助金额:
    $ 32.77万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Studies on the physiological roles of intracellular OLO chloride channels
细胞内OLO氯通道的生理作用研究
  • 批准号:
    14370316
  • 财政年份:
    2002
  • 资助金额:
    $ 32.77万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Analysis of urine concentrating mechanisms using the CLC-K1 null mice.
使用 CLC-K1 缺失小鼠分析尿液浓缩机制。
  • 批准号:
    12671028
  • 财政年份:
    2000
  • 资助金额:
    $ 32.77万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
CLC Chloride channels and diseases
CLC 氯离子通道与疾病
  • 批准号:
    09671155
  • 财政年份:
    1997
  • 资助金额:
    $ 32.77万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Development of membrane permeation inhibitors which are specific for kidney collecting duct, based on protein structure-function analysis.
基于蛋白质结构功能分析,开发肾集合管特异性膜渗透抑制剂。
  • 批准号:
    08557066
  • 财政年份:
    1996
  • 资助金额:
    $ 32.77万
  • 项目类别:
    Grant-in-Aid for Scientific Research (A)
Roles of cloned chloride channels in kidney chloride transport
克隆氯离子通道在肾脏氯离子转运中的作用
  • 批准号:
    07671241
  • 财政年份:
    1995
  • 资助金额:
    $ 32.77万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)

相似海外基金

CONDUCTION MECHANISM OF THE CLC CHLORIDE CHANNEL
CLC 氯化物通道的传导机制
  • 批准号:
    6977880
  • 财政年份:
    2004
  • 资助金额:
    $ 32.77万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了